Companies researching Canagliflozin
Canagliflozin is an SGLT2 inhibitor medication employed in the management of type 2 diabetes.
0
companies
Frequently asked questions
Canagliflozin is an SGLT2 inhibitor medication employed in the management of type 2 diabetes.
0
companies
Frequently asked questions